Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000010

Options or other derivatives

  • EVP, Chief Business Officer acquired 22,065 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +19,665 $37.58 2033-01-02 19,665 19,665 D
2023-01-03 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +2,400 $37.58 2033-01-02 2,400 2,400 I
Loading xslF345X03/edgardoc.xml…